GMAB

Genmab A/S

DK Healthcare Biotechnology

Latest week
17 Jul 2026
Close
1869.000000
Fair value
1826.621795
Next-week expectancy
Undecided 52.29%
Sharemaestro

GMAB Chart Pack

Genmab A/S

Exchange
CPH
Latest week
17 Jul 2026
Close
1869.000000
Fair value
1826.621795
Next-week expectancy
Undecided 52.29%
Generated
18 Jul 2026 13:25
Sector
Healthcare
Industry
Biotechnology

Chart Summary

Over the latest 12 completed weeks ending 2026-07-17, GMAB rose 10.33%, moving from 1,694.00 to 1,869.00. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -5.30 and has softened across the 12-week window. Market Dynamics is 0.77 on the latest week. Next-week expectancy is undecided at 52.29% based on similar historical setup states.

Key Points

Week Ending
17 Jul 2026
Latest Close
1,869.00
12-Week Change
10.33%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 52.29%
Signal Weeks
0 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
-5.30
Market Dynamics
0.77

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
17 Jul 2026
Latest Close
1,869.00
12-Week Change
10.33%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 52.29%
Signal Weeks
0 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
-5.30
Market Dynamics
0.77

Over the latest 12 completed weeks ending 2026-07-17, GMAB rose 10.33%, moving from 1,694.00 to 1,869.00. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -5.30 and has softened across the 12-week window. Market Dynamics is 0.77 on the latest week. Next-week expectancy is undecided at 52.29% based on similar historical setup states.

Industry Peers

Denmark equities in Biotechnology

Stock Exchange Week Open High Low Close Change
STRAP Strategic Partners A/S CPH 17 Jul 2026 575.00 640.00 560.00 640.00 11.30%
PEG Pharma Equity Group A/S CPH 17 Jul 2026 0.08 0.09 0.08 0.09 8.86%
ZEAL Zealand Pharma A/S CPH 17 Jul 2026 282.00 304.40 268.90 295.40 4.75%
BAVA Bavarian Nordic A/S CPH 17 Jul 2026 183.10 187.50 179.50 184.10 0.55%
ALK-B ALK-Abelló A/S CPH 17 Jul 2026 242.00 243.00 238.00 240.00 -0.83%
GUBRA Gubra A/S CPH 17 Jul 2026 355.60 364.80 328.80 342.00 -3.82%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.